123 related articles for article (PubMed ID: 37982361)
1. Very-high frequency plasmapheresis and donor health-absence of evidence is not equal to evidence of absence.
Van Remoortel H; van den Hurk K; Compernolle V; O'Leary P; Tiberghien P; Erikstrup C
Transfusion; 2023 Dec; 63(12):2358-2361. PubMed ID: 37982361
[No Abstract] [Full Text] [Related]
2. [Effects of plasmapheresis on the blood donors. Changes caused by long-term plasmapheresis in normal donors].
Pistotnik M; Grgicević D; Flego DG
Bilt Hematol Transfuz; 1975; 3(1-2):31-6. PubMed ID: 1225316
[TBL] [Abstract][Full Text] [Related]
3. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal blood volume of donors during automated intermittent-flow plasmapheresis and its relevance to the prevention of circulatory reactions.
Karger R; Slonka J; Junck H; Kretschmer V
Transfusion; 2003 Aug; 43(8):1096-106. PubMed ID: 12869116
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide serum concentration decreases in donors undergoing discontinuous plasmapheresis involving a large extracorporeal blood volume.
Karger R; Halbe M; Giffhorn-Katz S; Katz N; Kretschmer V
Transfusion; 2007 Sep; 47(9):1717-24. PubMed ID: 17725739
[TBL] [Abstract][Full Text] [Related]
6. Asking for something different from our donors: factors influencing persuasion success.
Bagot KL; Bove LL; Masser BM; White KM
Transfusion; 2014 Mar; 54(3 Pt 2):848-55. PubMed ID: 24274901
[TBL] [Abstract][Full Text] [Related]
7. Recruiting and retaining plasmapheresis donors: A critical belief analysis.
Bagot KL; Masser BM; White KM; Starfelt LC
Transfus Apher Sci; 2015 Jun; 52(3):350-7. PubMed ID: 25824702
[TBL] [Abstract][Full Text] [Related]
8. The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.
Tran-Mi B; Storch H; Seidel K; Schulzki T; Haubelt H; Anders C; Nagel D; Siegler KE; Vogt A; Seiler D; Hellstern P
Vox Sang; 2004 Apr; 86(3):189-97. PubMed ID: 15078254
[TBL] [Abstract][Full Text] [Related]
9. Understanding the plasmapheresis donor in a voluntary, nonremunerated environment.
Bove LL; Bednall T; Masser B; Buzza M
Transfusion; 2011 Nov; 51(11):2411-24. PubMed ID: 21564104
[TBL] [Abstract][Full Text] [Related]
10. A prospective multicentre study on the safety of long-term intensive plasmapheresis in donors (SIPLA).
Schulzki T; Seidel K; Storch H; Karges H; Kiessig S; Schneider S; Taborski U; Wolter K; Steppat D; Behm E; Zeisner M; Hellstern P;
Vox Sang; 2006 Aug; 91(2):162-73. PubMed ID: 16907878
[TBL] [Abstract][Full Text] [Related]
11. [PLASMAPHERESIS AS A SOURCE OF INCREASING THE RESOURCES OF DONOR BLOOD].
KISELEV AE; RUTBERG RA; MALLER AR; RODINA RI; PAPUSH ND; URINSON RM; LAVROVA OP; RAKHMAEVA VA
Probl Gematol Pereliv Krovi; 1964 Dec; 9():3-8. PubMed ID: 14312107
[No Abstract] [Full Text] [Related]
12. Treatment of congenital afibrinogenemia with cryoprecipitate collected through a plasmapheresis program using dedicated donors.
Thompson HW; Touris S; Giambartolomei S; Nuss R
J Clin Apher; 1998; 13(4):143-5. PubMed ID: 9886792
[TBL] [Abstract][Full Text] [Related]
13. Perceived deterrents to being a plasmapheresis donor in a voluntary, nonremunerated environment.
Bagot KL; Bove LL; Masser BM; Bednall TC; Buzza M
Transfusion; 2013 May; 53(5):1108-19. PubMed ID: 22998759
[TBL] [Abstract][Full Text] [Related]
14. Serum IgG and IgM levels in new and regular long-term plasmapheresis donors.
Burgin M; Hopkins G; Moore B; Nasser J; Richardson A; Minchinton R
Med Lab Sci; 1992 Dec; 49(4):265-70. PubMed ID: 1339930
[TBL] [Abstract][Full Text] [Related]
15. The risks of low hemoglobin deferral in a large retrospective cohort of plasmapheresis donors and the influence factors of return for a subsequent donation in China.
Xiao G; Dong D; Wang Y; Li C; Huang GT; Yang H; Huang J; Chen F
PeerJ; 2023; 11():e14999. PubMed ID: 36935911
[TBL] [Abstract][Full Text] [Related]
16. Donor vigilance data of a blood transfusion service: A multicenter analysis.
Burkhardt T; Dimanski B; Karl R; Sievert U; Karl A; Hübler C; Tonn T; Sopvinik I; Ertl H; Moog R
Transfus Apher Sci; 2015 Oct; 53(2):180-4. PubMed ID: 26074050
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiological study of hepatitis C virus (HCV) infection in plasmapheresis and blood donors].
Jin ZL; Chen SQ; Shi ZY
Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug; 16(4):234-6. PubMed ID: 7585906
[TBL] [Abstract][Full Text] [Related]
18. [Electrophoretic control of serum proteins in donors designated for plasmapheresis. Initial evaluation of the analysis of 3500 donors].
Fine JM; Marneux M; Sayarath V
Rev Fr Transfus Immunohematol; 1985 May; 28(2):125-36. PubMed ID: 4023543
[TBL] [Abstract][Full Text] [Related]
19. A donor safety evidence literature review of the short- and long-term effects of plasmapheresis.
Hoad VC; Castrén J; Norda R; Pink J
Vox Sang; 2024 Feb; 119(2):94-101. PubMed ID: 37641582
[TBL] [Abstract][Full Text] [Related]
20. Bringing new plasma donors back: testing the efficacy of telephone and e-mail communications with first-time donors.
Thorpe R; Masser BM; Nguyen L; Gemelli CN; Davison TE
Transfusion; 2020 Jul; 60(7):1463-1469. PubMed ID: 32319685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
